You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 2, Feb 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vaccinia Gangrenosa in Chronic Lymphatic Leukemia

Report of a Case with Recovery Following the Use of Vaccinia Immune Globulin

F. ROBERT FEKETY, JR., M.D.; STEPHEN E. MALAWISTA, M.D.; DAVID L. YOUNG, M.D.

Arch Intern Med. 1962;109(2):205-208.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since a successful smallpox vaccination is in a sense an iatrogenic disease, it is particularly unfortunate that patients with chronic lymphatic leukemia may develop a progressive necrotizing vaccinial infection (vaccinia gangrenosa) following this procedure. In the past, this complication has invariably been fatal.3 This is the report of an adult with chronic lymphatic leukemia who recovered from vaccinia gangrenosa with the aid of vaccinia immune globulin.

Report of Case

A 66 year old white retired postal worker was admitted to the hospital on June 22, 1959, because of weakness of 3 days' duration. He had been found to have chronic lymphatic leukemia in 1956 and had been treated with radiation and chlorambucil. One month before admission his hematocrit was 37%. He felt well until a few days before admission, taking chlorambucil, 2 mg/day. In preparation for a trip abroad, he was vaccinated by his private physician on June 17. . . . [Full Text PDF of this Article]


Author Affiliations

WEST HAVEN, CONN.

From the Medical Service, Veterans Administration Hospital, West Haven, Conn., and the Department of Medicine, Yale University School of Medicine, New Haven, Conn.; Formerly Resident in Medicine, Veterans Administration Hospital, West Haven, Conn., presently Instructor in Medicine, the Johns Hopkins University School of Medicine, Baltimore (Dr. Fekety); formerly Assistant Resident in Medicine, presently Clinical Associate, National Institutes of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Md. (Dr. Malawista); formerly Assistant Resident in Medicine, presently Assistant Resident in Medicine, Parkland Memorial Hospital, Dallas, Texas (Dr. Young).


Footnotes

Submitted for publication Dec. 29, 1960.

Supported in part by a Public Health Service Training Grant (2E-9), National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.